Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Select Medical Holdings (SEM) Debt to Equity (2018 - 2025)

Select Medical Holdings (SEM) has disclosed Debt to Equity for 8 consecutive years, with $1.07 as the latest value for Q4 2025.

  • On a quarterly basis, Debt to Equity rose 5.28% to $1.07 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.07, a 5.28% increase, with the full-year FY2025 number at $1.07, up 5.28% from a year prior.
  • Debt to Equity was $1.07 for Q4 2025 at Select Medical Holdings, up from $0.88 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $2.89 in Q2 2022 to a low of $0.88 in Q3 2025.
  • A 5-year average of $2.1 and a median of $2.4 in 2023 define the central range for Debt to Equity.
  • Peak YoY movement for Debt to Equity: skyrocketed 27463.5% in 2021, then tumbled 62.2% in 2025.
  • Select Medical Holdings' Debt to Equity stood at $2.7 in 2021, then rose by 6.1% to $2.86 in 2022, then dropped by 17.46% to $2.36 in 2023, then plummeted by 56.87% to $1.02 in 2024, then increased by 5.28% to $1.07 in 2025.
  • Per Business Quant, the three most recent readings for SEM's Debt to Equity are $1.07 (Q4 2025), $0.88 (Q3 2025), and $0.93 (Q2 2025).